Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1057 of 5804
-
New pill may help cancer patients avoid chemo delays due to low platelets
Disease control Not yet recruitingThe study consists of five sequential periods: * Screening (≤ 4 weeks) * Correction phase * Maintenance phase (first treatment cycle, Cycle 1) * Observation phase (second treatment cycle, Cycle 2) * Follow-up Eligible subjects are gynaecological-cancer patients who developed ≥ g…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for Crohn's patients: drug may stop disease return after surgery
Disease control Not yet recruitingThe goal of this single arm ,non-interventional, prospective, descriptive study is to evaluate the efficacy of guselkumab treatment in preventing endoscopic recurrence of Crohn's Disease in adult participants who have a documented diagnosis of moderate to severe CD and have under…
Sponsor: Shanghai 10th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Shock therapy at home? new trial tests brain zaps for speech loss
Symptom relief Recruiting nowThe goal of this clinical trial is to learn whether home-based brain stimulation combined with virtual speech-language therapy can improve communication abilities in adults with logopenic variant primary progressive aphasia (lvPPA), a language disorder most often caused by Alzhei…
Phase: NA • Sponsor: Maya Henry • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New study targets tough heart valve cases with advanced device
Disease control Not yet recruitingIn China, bicuspid aortic valve (BAV) represents a significantly high proportion of the transcatheter aortic valve replacement (TAVR) population. The application of TAVR in patients with BAV is challenging due to complex anatomy. To date, no prospective study has evaluated the Sa…
Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New antibody drug may boost transplant success in tough lymphoma
Disease control Not yet recruitingThis is an investigator-initiated, open-label, single-arm, multicenter, Phase II clinical study. The study is designed to evaluate the safety and potential effectiveness of glofitamab in adults with their disease, diffuse large B-cell lymphoma (DLBCL has either not responded to i…
Phase: PHASE2 • Sponsor: American University of Beirut Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Quick ER test could spot HIV and syphilis in pregnant women, saving babies
Diagnosis Not yet recruitingThe purpose of this study is to evaluate infection detection and treatment initiation rates for syphilis and HIV before and after integration of the Chembio DPP® HIV-Syphilis rapid POC test into an ongoing Emergency Department (ED) testing program and to determine whether dual ra…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Could stem cells restore ovarian function? new trial begins
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety, tolerability and efficacy of human umbilical cord mesenchymal stem cell injection (HS\_SW01 cells injection) in patients with Primary Ovarian Insufficiency (POI). Participants will be required to sign the informed consen…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Huishan Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New study aims to find best drainage technique for gallbladder infections in High-Risk patients
Disease control Recruiting nowThis multicenter, prospective, open-label, randomized controlled trial compares endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) with endoscopic transpapillary gallbladder drainage (EGBS) in poor surgical candidates with acute calculous cholecystitis. Eligible patients…
Phase: NA • Sponsor: Aichi Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New injection aims to control tough blood cancers in early trial
Disease control Not yet recruiting(Limit: 5000 characters) The purpose of this phase I clinical study aims to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of SYS6055 Injection in participants with relapsed/refractory B-cell malignancies, and to provide evidence for r…
Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New online program aims to ease trauma in young cancer survivors
Symptom relief Not yet recruitingThe goal of this study is to develop a virtual group intervention to address post-traumatic stress related to cancer in young adult cancer survivors (YACs, aged 18-39). The study team will do this by integrating evidence-guided treatments and expert clinician feedback (N=10) on t…
Phase: NA • Sponsor: Zeba Ahmad, Ph.D. • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
AI-Generated cartoon video may calm kids before shots and blood tests
Symptom relief CompletedChildren frequently experience anxiety, pain, and negative behavioral changes during common medical procedures such as venous blood sampling, vaccination, injection, and peripheral intravenous catheter insertion. Providing developmentally appropriate procedural preparation before…
Phase: NA • Sponsor: Istanbul Bilgi University • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New hope for weight regain after gastric bypass: TORe procedure tested
Disease control Recruiting nowThe goal of this clinical trial is to evaluate weight loss with TORe and intensive lifestyle modification versus intensive lifestyle modification alone in subjects who have regained weight following a Roux-en-Y gastric bypass. Participants will randomized 2:1. Those randomized t…
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New emergency room program aims to stop back pain from becoming chronic
Symptom relief Recruiting nowAcute low back pain, the second leading cause of medical consultations in France, poses a major public health challenge, particularly because of its high risk of progressing to chronic low back pain-the leading cause worldwide of years lived with disability. Pharmacological treat…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New combo therapy tracked in german men with spread prostate cancer
Disease control Recruiting nowProstate cancer is a disease where cells in the prostate gland grow out of control. When prostate cancer has spread to other parts of the body but still responds to hormone treatment, it is called metastatic hormone-sensitive prostate cancer (mHSPC). The usual treatment for this…
Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Pre-Treatment workouts and diet may boost breast cancer recovery
Symptom relief Recruiting nowBreast cancer (BC) is the most common cancer among women worldwide. Cancer treatments are associated with numerous adverse events that reduce patients' functionality and alter their clinical and molecular profiles. Physical exercise and adherence to nutritional guidelines during …
Phase: NA • Sponsor: European University Miguel de Cervantes • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Could a headset at home lift depression? new trial investigates
Symptom relief Recruiting nowThe purpose of this multicentric randomized controlled trial is to compare the effectiveness and safety of home-based tDCS for the treatment of major depression versus tDCS treatment in a healthcare centre, and explore the effects of an accelerated home-tDCS protocol. The change…
Phase: NA • Sponsor: Ionclinics & Deionic SL • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Could a single session of brain zaps and talk therapy lift depression?
Symptom relief Recruiting nowThe purpose of this study is to primarily assess the feasibility and secondarily assess the efficacy of a single session intervention (SSI) that combines non-invasive brain stimulation and psychotherapy for Major Depressive Disorder (MDD). investigators will recruit 30 people wit…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New shot aims to recolor white patches in vitiligo
Disease control Recruiting nowThe purpose of this study is to evaluate how well LY4005130 is tolerated and what side effects may occur in participants with non-segmental vitiligo (NSV) when compared with placebo. The study drug will be administered intravenously (IV) (into a vein in the arm). Blood tests wil…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New IV drug hopes to regrow hair in severe alopecia
Disease control Recruiting nowThe purpose of this study is to evaluate how well LY4005130 works in participants with severe alopecia areata (hair loss) when compared with placebo, and how well it's tolerated and what side effects may occur. Blood tests will be performed to investigate how the body processes t…
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New shot aims to boost platelets in bleeding disorder
Disease control Recruiting nowThe goal of this clinical trial is to demonstrate GL-2045 safety and efficacy proof of concept by demonstrating intravenous immunoglobulin (IVig)-like platelet responses in adult patients with Immune Thrombocytopenia (ITP).
Phase: PHASE1 • Sponsor: Gliknik Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC